Benzinga | Aug 17, 2021 09:27AM EDT

Petros Pharmaceuticals Q2 EPS $(0.22), Sales $2.46M

Petros Pharmaceuticals (NASDAQ:PTPI) reported quarterly losses of $(0.22) per share. The company reported $2.46 million in sales this quarter.